AI assistant
Sending…
Ascletis Pharma Inc. — Earnings Release 2001
Sep 18, 2001
50081_rns_2001-09-18_d711516c-17fe-4f74-8276-9ec3cad31cff.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| WORLD HOUSEWARE<00713> - Results Announcement (Summary) World Houseware (Holdings) Limited announced on 18/9/2001: (stock code: 713) Year end date: 31/12/2001 Currency: HK$ (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/1/2001 from 1/1/2000 to 30/6/2001 to 30/6/2000 ('000) ('000) Turnover : 313,405 335,666 Profit/(Loss) from Operations : 21,721 21,908 Finance cost : (5,519) (5,314) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : - - Profit/(Loss) after Tax & MI : 15,230 12,455 % Change over Last Period : +22% EPS/(LPS)-Basic : 2.3 cents 1.9 cents -Diluted : 2.0 cents 1.8 cents Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : 15,230 12,455 Interim Dividend per Share : 0.5 cent 0.5 cent (Specify if with other options) : N/A (with scrip option) B/C Dates for Interim Dividend : 9/10/2001 to 15/10/2001 bdi. Payable Date : 5/11/2001 B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : N/A B/C Dates for Other Distribution : N/A Remarks: (1) The Group has adopted SSAP 30 "Business combinations" ("SSAP 30") and has elected to restate goodwill previously eliminated against reserves. Accordingly, the amount of such goodwill, that amounted to HK$182,000 for the first half of year 2000, has been remeasured. (2) Earnings per share 1/1/2001 1/1/2000 to 30/6/2001 to 30/6/2000 HK$'000 HK$'000 Earnings for the purpose of calculating basic earnings per share 15,230 12,455 Interest on convertible redeemable note 1,213 667 ---------- ---------- Earnings for the purpose of calculating diluted earnings per share 16,443 13,122 ========= ========= Weighted average number of shares for the purpose of calculating basic earnings per share 672,422,407 668,893,318 Potential dilutive shares issuable under: Convertible redeemable note 132,000,000 72,527,473 Share option scheme - 164,412 ---------------- ---------------- Weighted average number of shares for the purpose of calculating diluted earnings per share 804,422,407 741,585,203 =========== =========== The computation of diluted earnings per share in the current period does not take into consideration the exercise of the Company's outstanding share options as the exercise price of those options is higher than the average market price of the Company's shares during the period. |
More from Ascletis Pharma Inc.
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Earnings Release
2026
Mar 31
Report Publication Announcement
2026
Mar 18
Regulatory Filings
2026
Mar 17
